Stryker announced today that it received FDA 510(k) clearance for its OptaBlate basivertebral nerve ablation system ...

Stryker's first ... a long history in radiofrequency ablation, and we're relentlessly committed to delivering groundbreaking approaches to protect and promote quality of life," said Kristen ...

The charge, which is Stryker’s estimate of what it will cost to settle the probe into marketing practices concerning its OtisKnee device, is expected to reduce its reported diluted earnings per ...

offered $33 million to the United States Department of Justice on May 31 to end a probe into marketing practices ... who is serving as Stryker's interim chief executive officer, as well as the ...